Sanofi
- Country
- 🇫🇷France
- Ownership
- Public
- Employees
- 87.9K
- Market Cap
- $141.3B
- Website
- http://www.sanofi.com
- Introduction
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
Efficacy and Safety of Rimonabant as an Aid to Maintenance of Smoking Cessation
- Conditions
- Maintenance of Smoking Cessation
- First Posted Date
- 2007-04-11
- Last Posted Date
- 2009-04-07
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 4850
- Registration Number
- NCT00459173
- Locations
- 🇨🇦
Sanofi-Aventis, Laval, Quebec, Canada
Japanese Dose-Response Study of Rimonabant in Obese Patients
- Conditions
- Obesity
- First Posted Date
- 2007-04-11
- Last Posted Date
- 2009-04-07
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 527
- Registration Number
- NCT00459004
- Locations
- 🇯🇵
Sanofi-Aventis, Tokyo, Japan
Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors
- Conditions
- ObesityMicroalbuminuriaDiabetes Mellitus, Type 2Dyslipidemia
- Interventions
- Drug: Placebo
- First Posted Date
- 2007-04-09
- Last Posted Date
- 2010-12-10
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 174
- Registration Number
- NCT00458081
- Locations
- 🇪🇸
Sanofi-Aventis Administrative Office, Barcelona, Spain
A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older
- Conditions
- PertussisTetanusDiphtheria
- First Posted Date
- 2007-04-06
- Last Posted Date
- 2012-10-19
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 1564
- Registration Number
- NCT00457249
ENterogermina® (Bacillus Clausii) In the manaGeMent of diarrheA in Children
- Conditions
- Gastroenteritis
- Interventions
- Other: Oral rehydration therapy
- First Posted Date
- 2007-04-06
- Last Posted Date
- 2009-01-21
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 264
- Registration Number
- NCT00457353
- Locations
- 🇮🇳
Sanofi-Aventis, Mumbai, India
Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients
- Conditions
- InfectionFebrile Neutropenia
- Interventions
- First Posted Date
- 2007-03-30
- Last Posted Date
- 2009-03-06
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 197
- Registration Number
- NCT00454272
- Locations
- 🇹🇷
Sanofi aventis administrative office, Istanbul, Turkey
ALF-STONE: Alfuzosin in Uretheric Stones
- Conditions
- Prostatic Hyperplasia
- First Posted Date
- 2007-03-30
- Last Posted Date
- 2007-09-24
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 220
- Registration Number
- NCT00454402
- Locations
- 🇵🇹
Sanofi-Aventis, Lisbon, Portugal
Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months
- Conditions
- DiphtheriaTetanusHaemophilus Influenzae Type bPertussisPoliomyelitis
- Interventions
- Biological: Diphtheria, Tetanus, Polio, Acellular Pertussis and HibBiological: Diphtheria, Tetanus, & Acellular Pertussis Combined, Absorbed
- First Posted Date
- 2007-03-29
- Last Posted Date
- 2012-04-17
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 792
- Registration Number
- NCT00453570
Alfuzosin Versus Placebo in Acute Urinary Retention
- Conditions
- Urinary Retention
- First Posted Date
- 2007-03-29
- Last Posted Date
- 2007-08-20
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 160
- Registration Number
- NCT00453908
- Locations
- 🇩🇰
Sanofi-Aventis, Hoersholm, Denmark
Risedronate Sodium in Post Menopausal Osteoporosis
- Conditions
- Osteoporosis, Postmenopausal
- First Posted Date
- 2007-03-29
- Last Posted Date
- 2008-03-11
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 246
- Registration Number
- NCT00453492
- Locations
- 🇹🇷
Sanofi-Aventis, Istanbul, Turkey